spacer
home > pmps > summer 2007 > the therapeutics of injections
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Therapeutics of Injections

Kevin Maynard, Business Development Director at Imprint Pharmaceuticals Ltd, investigates the solublisation and recovery of injectable pharmaceutical materials, and the importance of usability and safety for end users

Many injectable drugs need to be reconstituted either at home or in the clinic. Special devices have been developed to improve the reproducibility, simplicity and safety of the reconstitution of these therapies for end users, including healthcare workers and patients.

Pharmaceutical companies are becoming ever more successful in bringing the fruits of the human genome project to market. Treatment of diseases such as cancer, rheumatoid arthritis, Crohnís disease and diabetes are being transformed by these therapies. However, many of the therapies require injection and, hence, come with all the complications, both technical and presentational, that injectable therapies bring.

Many of these therapies require frequent injections; depending on the nature of the disease and the patientís individual condition, those injections could be weekly, daily, or even more frequent.

Many injectable therapeutics are stored as powders; they are more stable in this form. Therapeutics stored as a powder need to be solublised with a liquid diluent and transferred to an injection device before being injected, resulting in an additional operation for untrained users to carry out. This step can be quite complex, with multiple variants in the reconstitution process depending on the therapy, the delivery device and the userís setting and knowledge. This creates significant issues for those unaware of the problem.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Kevin Maynard is the Business Development Director of Imprint Pharmaceuticals Ltd, a company focused on providing solutions to the reconstitution and delivery of complex formulations. Over the last 10 years, Kevin has concentrated his efforts on providing clients with practical technology to solve some of the most intractable problems in managing complex fluids at the bedside or clinic. He has a PhD in Pharmacology and 20 yearsí experience in drug delivery, cancer biology and therapeutic formulations.
spacer
Kevin Maynard
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

The Latest Innovations in HPAPI Manufacturing Technologies

SMiís inaugural Highly Potent Active Pharmaceutical Ingredients USA Conference, will focus on the latest innovative manufacturing technologies with a special spotlight presentation on effective and safe containment solutions for biologics based HPAPIs, along with cleaning and cross contamination requirements.
More info >>

White Papers

Medpace Reference Laboratories establishes state of the art Flow Cytometry techniques for flexible approaches to clinical trials across multiple therapeutic areas.

Medpace

Cytometry is the process of measuring the properties of individual cells. These properties may include gene or protein expression, chemical properties, deoxyribonucleic acid (DNA) content, and various cellular functions. The earliest methods of cytometry relied upon light microscopy for the classification and observation of cells and cellular components. Microscopy permitted direct visual observation of cells for the first time, leading to the classification of cells by morphology and insight into cellular functions. However, the time required for microscopic analysis constrains the number of samples or number of cells in each sample that can be examined. Therefore, the utility of microscopy for analysis of rare cells or in situations where sample throughput is a priority is limited. Flow cytometry was developed largely to improve upon these limitations.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement